Category: ACQUISITIONS and MERGERS

Abdul Mutlib, CEO of Frontage Laboratories.  "Nucro-Technics has been recognized as a leader in the Canadian CRO market for over 50 years, and its unparalleled client services are a perfect match for the culture of Frontage Laboratories.  This acquisition not only significantly strengthens our presence in Canada, but also will enable the combined organization to offer a more expansive suite of services to clients across the globe.  We are looking forward to partnering with the Nucro team to deliver the world-class expertise that clients have come to expect from us."

Thomas Scientific's CEO, Stan Haas, stated, "We at Thomas Scientific are very proud to partner with an industry veteran in Billy Day and his entire team. Billy has built a business over the past 45 years founded on providing personalized service and many great product brands to meet the stringent needs of their customers. By Day Associates joining the Thomas Scientific family of companies, the customers will have access to an even broader portfolio of products and a national network of distribution centers and inventory to meet their needs now and into the future."

"MD Revolution offers not only extensive experience but also the best technology platform, and proven SaaS offering, to serve our growing client base" said Rick Griffin, CEO, NavCare. "We share the same culture and desire to provide exceptional personalized care to our patients, along with maintaining the highest clinical standards."

The acquisition not only expands Neogap's patent portfolio but also enhances the company's pipeline of potential candidates for future preclinical and clinical development.

Peter Mountney, Ph.D., CEO of Odin Vision commented, "We are excited to set the stage for future innovation development by leading Olympus' plans for the first DECs, all in the pursuit of empowering clinicians to deliver the best possible care and outcomes to patients using the latest digital and AI tools."

In the past decade or so, the additive manufacturing industry has been characterized by an ever-increasing number of hardware players trying to capture their own share of the market. While there were signs of consolidation in the early 2010s, given major moves by industry leaders like Stratasys and 3D Systems, AM has instead seen a consistent stream of newcomers with their own innovative takes on AM, such that IDTechEx now segments their 3D printing hardware forecast by seventeen different categories to account for such diversity.

“The acquisition of Somryst aligns seamlessly with Nox's mission of promoting science-based solutions that address chronic diseases through sleep care management. As an outcomes-driven company with ten years of real-world data, it was important for us to find a solution with equal depth in validation and outcomes data, thereby setting it apart from other CBT-I solutions,” said Sigurjon Kristjansson, CEO of Nox Health.

"We're thrilled to accelerate our next phase of growth with a partner like Medtronic who shares our goal of simplifying diabetes management to make life easier for the customers we serve," said Jesse J. Kim, CEO and founder of EOFlow. "Together, we'll work to advance innovation in wearable insulin patch technology to expand our reach to more individuals around the world living with diabetes. With a global footprint in over 100 countries, ability to scale up manufacturing quickly, and advanced software and sensor capabilities, Medtronic is the ideal strategic partner for EOFlow."